A Stimulating Conversation with Oxurion CEO Patrik De Haes, MD

With a medical career spanning 35 years, including as global head of immunology at Sandoz (now Novartis), Patrik De Haes, MD, has cultivated deep experience turning scientific ambition into life-changing reality. In this unmissable episode, we talk to Dr. De Haes, now CEO of Brussels-based Oxurion, to get a deeper look at the business, research, and cultural elements that drive a product’s journey from concept to commercial. Tune in now.